curasan AG (Germany) Profile

0.61
EUR 0.08  15.09%

curasan AG Summary

curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 38 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 13.39M. curasan AG classifies itself under Healthcare sector and is part of Biotechnology industry. This company has 15.57M outstanding shares. CURASAN has accumulated about 465K in cash with (3.34M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check curasan AG Probability Of Bankruptcy

curasan AG Target Price Odds Analysis

Odds Below 0.61HorizonTargetOdds Above 0.61
12.80%30 days 0.61 87.15%
Based on normal probability distribution, the odds of curasan AG to move above current price in 30 days from now is about 87.15% (This curasan AG probability density function shows the probability of curasan AG Stock to fall within a particular range of prices over 30 days) .

curasan AG Risk Profiles

curasan AG Key Fundamentals

curasan AG Against Markets

curasan AG Current Ratings

curasan AG 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0
Chance of
Financial Distress (0 to 100%)
24%
Equity ratings for curasan AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
curasan AG, together with its subsidiaries, develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. Its products include CERASORB, a bone replacement material stypro, a sterile and porous sponge for hemostasis Curavisc, a hyaluronic acid for the treatment of osteoarthritis Osbone, a synthetic opencell cancellous bone graft material for filling bone defects and augmentation of the atrophied alveolar ridge foils and membranes for use in dental and oral surgeries and accessories, such as fixation systems for use in bone augmentation surgery. curasan AG was founded in 1988 and is headquartered in Kleinostheim, Germany. curasan AG operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38 people. more
Namecurasan AG
CEORichard GarrView All
Macroaxis Advice
Specialization
Healthcare, Healthcare Products
InstrumentGermany Stock View All
Business AddressLindigstrasse 4
Foreign Associate  USA
ExchangeFrankfurt Stock Exchange
ISINDE0005494538
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.curasan.de
Phone49 6027 40 900 0
CurrencyEUR - Euro
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017

curasan AG Directors

curasan AG Corporate Directors

William Oldaker Independent Director
Stanley Westreich Independent Director
Scott Ogilvie Independent Director
Check also Trending Equities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Search macroaxis.com